Plunkett Research Online: Reata Pharmaceuticals

REATA PHARMACEUTICALS (RETA) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Reata Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing therapeutics to address serious and life-threatening diseases by targeting molecular pathways. The company's product in the pipeline include bardoxolone methyl; Omaveloxolo.....


REATA PHARMACEUTICALS

Ticker: RETA
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 972 865-2219
Fax:
Address: 2801 Gateway Drive
Irving, TX 75063 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

J. Warren HuffCEO/Chairman of the Board/Director
Manmeet SoniCFO/COO/President
See More
Reata Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing therapeutics to address serious and life-threatening diseases by targeting molecular pathways. The company's product in the pipeline include bardoxolone methyl; Omaveloxolo.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture